Ftse Mib
33.154,05
-0,10%
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
61.044,73
1,22%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Unicycive Therapeutics Inc (UNCY) Unicycive Therapeutics Inc (UNCY) Notizie

UNCY

Unicycive Therapeutics (UNCY)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:UNCY
DataOraFonteTitoloSimboloCompagnia
25/06/202413:30GlobeNewswire Inc.Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical TrialNASDAQ:UNCYUnicycive Therapeutics Inc
28/05/202413:03GlobeNewswire Inc.Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association CongressNASDAQ:UNCYUnicycive Therapeutics Inc
23/05/202413:03GlobeNewswire Inc.Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
15/05/202413:03GlobeNewswire Inc.Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical MeetingNASDAQ:UNCYUnicycive Therapeutics Inc
13/05/202422:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
13/05/202422:16GlobeNewswire Inc.Unicycive Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
13/05/202422:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UNCYUnicycive Therapeutics Inc
08/05/202422:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:UNCYUnicycive Therapeutics Inc
10/04/202413:03GlobeNewswire Inc.Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
28/03/202421:15GlobeNewswire Inc.Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
25/03/202412:03GlobeNewswire Inc.Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association CongressNASDAQ:UNCYUnicycive Therapeutics Inc
14/03/202412:03GlobeNewswire Inc.Unicycive Announces $50 Million Private PlacementNASDAQ:UNCYUnicycive Therapeutics Inc
13/03/202412:03GlobeNewswire Inc.Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
07/03/202422:12GlobeNewswire Inc.Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)NASDAQ:UNCYUnicycive Therapeutics Inc
04/03/202413:03GlobeNewswire Inc.Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant PatientsNASDAQ:UNCYUnicycive Therapeutics Inc
14/02/202413:03GlobeNewswire Inc.Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical MeetingNASDAQ:UNCYUnicycive Therapeutics Inc
29/01/202413:03GlobeNewswire Inc.Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
23/01/202413:03GlobeNewswire Inc.Unicycive Therapeutics Issues Shareholder Letter to Highlight Corporate Progress and Key Upcoming MilestonesNASDAQ:UNCYUnicycive Therapeutics Inc
22/01/202422:27Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:UNCYUnicycive Therapeutics Inc
18/12/202313:03GlobeNewswire Inc.Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on DialysisNASDAQ:UNCYUnicycive Therapeutics Inc
08/12/202322:36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:UNCYUnicycive Therapeutics Inc
29/11/202313:03GlobeNewswire Inc.Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023NASDAQ:UNCYUnicycive Therapeutics Inc
14/11/202322:15GlobeNewswire Inc.Unicycive Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
23/10/202313:03GlobeNewswire Inc.Unicycive Therapeutics Reaches Alignment with the FDA on Path to File New Drug Application for Oxylanthanum Carbonate (OLC)NASDAQ:UNCYUnicycive Therapeutics Inc
07/09/202322:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
07/09/202322:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
06/09/202313:03GlobeNewswire Inc.Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhDNASDAQ:UNCYUnicycive Therapeutics Inc
29/08/202313:03GlobeNewswire Inc.Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight SeriesNASDAQ:UNCYUnicycive Therapeutics Inc
14/08/202323:36GlobeNewswire Inc.Unicycive Announces Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
04/08/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:UNCYUnicycive Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:UNCY

La tua Cronologia

BIT
UB4QDE
Unicredit Bank
BIT
F15374
Vontobel Financial Produ...
BIT
UC72MM
Unicredit Bank
BIT
UV4KSW
UniCredit Bank
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network